PATENT CLAIM ANALYSIS

Application Number: 16170446
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2020-01
Patent Classification: ["514", "338000"]

Abstract:
Pharmaceutical preparations include at least one component that enhances sexual response and at least one other compound that enhances sexual sensitivity and pleasure. The component that enhances sexual response enhances blood flow to the genital region. Examples include compounds that dilate blood vessels, such as compounds that increase the amount of nitric oxide (NO) in the blood. The component that enhances sexual sensitivity and pleasure includes one or more cannabinoid compounds from the plant genus  Cannabis , including extracted compounds, synthetic forms, and derivatives thereof. Examples include tetrahydrocannabinol (THC), the main psychoactive constituent of  Cannabis , and cannabidiol (CBD), which is less or non-psychoactive and modulates THC activity. The ratio of THC/CBD can be selected depending on age, gender, physical health, and/or psychological condition of the user.

Claim (Index 6):
The method of  claim 1 , wherein the cannabinoid component comprises tetrahydrocannabinol and/or cannabidiol, and at least one other cannabinoid other than tetrahydrocannabinol and cannabidiol.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 97.0
- Lexical Diversity: 1.79268
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15642685', '16056726', '14538527', '15676407', '10750743']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8035953394532934
- 35 USC 102 Novelty (BERT): 0.6298641818762828
- Combined Prediction Score: 0.7862222236955924
- Mean Citation Score: 424.678784
- Max Citation Score: 599.00214
- Similarity Product: 540.9118910076892

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test